![]() |
|
|
Vol. 27, Issue 8, 909-915, August 1999
Department of Pharmacology,
| |
Abstract |
|---|
|
|
|---|
The effect of medium formulation, composition of extracellular matrix overlay, and culture dish material on liver microsomal cytochrome P-450 (CYP) 2B induction by phenobarbital (PB) was investigated in primary cultures of rat hepatocytes. When hepatocytes were maintained on Permanox dishes with an overlay of either collagen (type I) or Matrigel, Williams' E medium was superior to other medium formulations in terms of the magnitude of induction of CYP2B on a per milligram microsomal protein basis. Modified Chee's medium (MCM) and hepatocyte culture medium were intermediate in their capacity to sustain induction of CYP2B by PB, and Dulbecco's modified Eagle's medium was slightly less effective. The overall induction of CYP2B activity by PB was, on average, 50% lower in hepatocytes cultured on polystyrene dishes (LUX). Little or no difference was observed between hepatocytes overlaid with collagen and those overlaid with Matrigel. MCM was superior to Williams' E medium in terms of the yield of microsomal protein and the ultrastructural features of the hepatocyte monolayers. CYP2B induction by PB was optimal after 3 days of treatment in either medium. CYP1A, CYP3A, and CYP4A activities could be induced in vitro by prototypical inducing agents in hepatocytes cultured on Permanox dishes with MCM and a Matrigel overlay to comparable levels observed in vivo. The results of these studies show that medium formulation and culture vessel material, but not the type of extracellular matrix overlay, have significant effects on the induction of CYP enzymes in cultured rat hepatocytes maintained in a sandwich configuration.
| |
Introduction |
|---|
|
|
|---|
Over
the past two decades significant efforts have been made to establish
primary cultures of rat hepatocytes in which microsomal cytochrome
P-450 (CYP)3 enzymes belonging to the CYP2B
subfamily are maintained and/or induced as they are in vivo (LeCluyse
et al., 1996b
). In vivo liver microsomes from untreated rats contain
undetectable levels of immunoreactive CYP2B1 and low levels (10-40
pmol/mg) of CYP2B2 (Thomas et al., 1987
; Ryan and Levin, 1990
). The
levels of CYP2B1 and CYP2B2 in rat liver microsomes are coordinately
regulated in a dose-dependent manner by phenobarbital (PB) and PB-type
inducers (Adesnik et al., 1981
; Waxman et al., 1990
). The marked
induction (~50-fold) of CYP2B1 and CYP2B2 enzymes involves
transcriptional activation of their respective genes by mechanisms that
have yet to be fully elucidated.
Three factors have been consistently shown to have significant effects
on CYP enzyme expression and induction in vitro. These are: 1) the
biophysical nature and composition of the extracellular matrix
(Ben-Ze'ev et al., 1988
; Lindblad et al., 1991
), 2) the formulation of
culture medium (Jauregui et al., 1986
; Turner and Pitot, 1989
), and 3)
the combination and concentration of hormones (Dich et al., 1988
; Dahn
et al., 1993
). Unfortunately, direct comparisons of rat hepatocyte
culture protocols designed to study CYP expression are complicated by
the number of culture variables and the interdependence of substratum,
extracellular matrix overlay, medium formulation, and hormone
supplementation. Comparisons between various studies are also
complicated by the endpoints used to monitor CYP expression. For
example, Sidhu et al. (1993)
have shown that modified Williams' E
medium (WEM) and modified Chee's medium (MCM) are equally effective in
supporting induction of CYP2B mRNA by PB, but the latter is superior in
supporting induction of CYP2B protein and activity. The age of the
cultures before inducers are introduced, the relative potency of
inducers within each class, the final concentration of inducers in
culture medium, and the duration of exposure to inducers also have
profound effects on the induction of CYP enzymes in cultured
hepatocytes. Therefore, the purpose of this study was to determine the
effects of a number of culture conditions on the overall cell
morphology and the induction of CYP2B enzymes by PB in long-term
cultures of rat hepatocytes.
Four medium formulations, namely, Dulbecco's modified Eagle's medium
(DMEM), WEM, MCM, and hepatocyte culture medium (HCM), were chosen to
represent both conventional formulations, which are easily obtained
commercially (WEM, DMEM) and "enriched" formulations, which contain
superphysiological concentrations of certain components, such as amino
acids (MCM, HCM). Collagen and Matrigel overlay were compared because
both represent matrix components found in the space of Disse, yet are
expressed during different stages of hepatocyte differentiation
(laminin = fetal; collagen = mature; Reid et al., 1992
).
However, Matrigel is thought to be superior to collagen in its ability
to restore the differentiated phenotype to cultured hepatocytes,
presumably because of its complex nature (laminin, collagen type IV,
entactin, etc.; Berry et al., 1991
). Finally, two commonly used,
commercially available types of culture dishes [polystyrene (LUX) and
Permanox] were compared for their influence on PB-induced CYP2B enzyme expression.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
All culture media, sera, glutaMAX media supplement, and nonessential
amino acids were obtained from Gibco BRL (Grand Island, NY).
Insulin, transferrin, selenium, linoleic acid, and BSA supplement (ITS+) and Matrigel were purchased from Collaborative Biomedical Research (Bedford, MA). Collagenase (CLS 2) was obtained from Worthington Biochemical Corporation (Lakewood, NJ). Collagen, type I
(Vitrogen) was obtained from CelTrix (Santa Clara, CA). Petri dishes
(60 mm) (LUX, Permanox) were purchased from NUNC (Naperville, IL). The
sources of the various steroids and other reagents used in this study
have been reported previously (Sonderfan et al., 1987
; Pearce et al.,
1996
).
Isolation and Culture of Rat Hepatocytes.
Hepatocytes were isolated from rat liver by a modification of the
collagenase digestion method described by LeCluyse et al. (1996a)
,
which was adapted from the method of Quistorff et al. (1989)
. Briefly,
rat livers were perfused with calcium-free buffer containing 5.5 mM
glucose and 0.5 mM EGTA for 10 min at a flow rate of 35 to 40 ml/min
followed by perfusion with buffer containing 1.5 mM calcium and
collagenase (0.3-0.4 mg/ml) for 10 to 15 min at a flow rate of 30 to
35 ml/min. Hepatocytes were dispersed from the digested liver in DMEM
containing 5% fetal calf serum, insulin (4 µg/ml), and dexamethasone
(1 µM) and washed by low-speed centrifugation (50g, 2 min). Cell pellets from rat liver were resuspended in equal volumes of
medium and 90% isotonic Percoll and centrifuged at 70g for
5 min. The resultant pellets were resuspended in fresh medium and
washed once by low-speed centrifugation. Hepatocytes were resuspended
in supplemented DMEM and viability was determined by trypan blue
exclusion. Cell preparations were not used for experimental studies
unless the viability was
85%.
Induction Studies.
Medium and overlay effects
Hepatocytes were plated onto Permanox or LUX culture dishes precoated
with collagen, type I, according to the methods of Waxman et al.
(1990)
. After cell attachment, monolayers were overlaid with either
ice-cold neutralized collagen or ice-cold medium containing 0.25 mg/ml
Matrigel as described by LeCluyse et al. (1996a)
. In addition, groups
of hepatocyte cultures (n = 5-6 per treatment group) were
maintained in one of four medium formulations: DMEM, WEM, MCM, or HCM.
These procedures produced eight different groups of hepatocyte cultures
based on type of medium and composition of the matrix overlay.
Monolayers from each group were subsequently maintained for 2 to 3 days
in the corresponding serum-free medium supplemented with ITS+ and 0.1 µM dexamethasone before initiating treatment with inducers. Groups of
hepatocyte cultures were then treated for 3 consecutive days with
either saline (control) or 100 µM PB. At the end of the study period,
cells were harvested for the preparation of microsomes.
Time course of CYP enzyme induction. Hepatocytes were plated onto Permanox culture dishes and overlaid with Matrigel as described above. Hepatocytes were maintained in MCM supplemented with ITS+ and 0.1 µM dexamethasone before initiating treatment with inducers. Groups of hepatocyte cultures (n = 5-6 dishes per treatment group) were then treated for 1 to 4 consecutive days with 0.1% dimethyl sulfoxide (control) or 100 µM PB. At the appropriate time point, cells from the corresponding groups were harvested for the preparation of microsomes.
Dose response of P-450 enzyme induction. Hepatocytes were plated onto Permanox culture dishes and overlaid with Matrigel as described above. Hepatocytes were maintained in either WEM or MCM supplemented with ITS+ and 0.1 µM dexamethasone before initiating treatment with PB. Groups of hepatocyte cultures (n = 5-6 dishes per treatment group) were then treated for 3 consecutive days with either 10, 25, 100, 250, 750, or 1500 µM PB. Control cultures were treated with saline vehicle alone. At the end of the study period, cells were harvested for the preparation of microsomes.
Cell harvest and microsome preparation.
At the appropriate time points, cultures of hepatocytes from each
treatment group were rinsed twice with ice-cold phosphate-buffered saline. Homogenization buffer (50 mM Tris-HCl, pH 7.0, 150 mM KCl, 2 mM EDTA; 0.5 ml/dish) was added to each dish and cells were
scraped with a rubber policeman. Harvested cells from each treatment
were then pooled and sonicated with a Vibra-Cell probe sonicator
(Sonics & Materials, Danbury, CT) at 40 W for 15 to 20 s
(Wortelboer et al., 1990
). Cell lysates were centrifuged at
9000g for 20 min at 4°C. Supernatant fractions were
collected and centrifuged at 100,000g for 60 min at 4°C.
The final microsomal pellets were resuspended in 0.25 to 0.5 ml of 0.25 M sucrose with the aid of a Dounce homogenizer fitted with a Teflon
pestle. A small aliquot was taken for protein determination and all
samples were subsequently stored at
80°C.
Protein determination. The concentration of protein was determined with a commercially available kit (BCA Protein Assay kit; Pierce Chemical Co., Rockford, IL) with bovine serum albumin as a standard (supplied with the BCA Protein Assay kit).
P-450 enzyme activities.
7-Ethoxyresorufin and 7-pentoxyresorufin O-dealkylase
(PROD), testosterone, and lauric acid hydroxylase activities were
determined as described by Pearce et al. (1996)
.
SDS-polyacrylamide gel electrophoresis and Western
immunoblotting.
The levels of CYP2B in rat hepatocyte microsomes were determined by
Western immunoblot analysis with polyclonal antibodies against purified
rat liver microsomal enzymes as described previously (Parkinson and
Gemzik, 1991
).
Electron microscopy. Hepatocyte cultures were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, for 20 to 30 min. Cultures were then postfixed with 1% OsO4 for 30 min, stained en bloc with 1% uranyl acetate, dehydrated in an acetone series, and embedded in Epon resin. Thin sections were cut perpendicular to the plane of the monolayer, poststained with uranyl acetate and lead citrate, and viewed with a JEOL 1200EXII electron microscope.
Statistical analysis.
Data were analyzed for statistically significant differences between
control and treated rat hepatocyte cultures by Dunnett's two-way ANOVA
at the 5% level of significance (Dunnett, 1964
).
| |
Results |
|---|
|
|
|---|
Media and Overlay Effects on P-450 Enzyme Induction. Hepatocytes were cultured on a simple substratum of collagen, type I, with one of four different medium formulations. In addition, cultures were overlaid with a top layer of either collagen (type I) or Matrigel. Hepatocyte cultures were then examined for the induction of CYP2B by the prototypical inducer PB. The effects of medium formulation and matrix overlay on microsomal PROD activity in primary cultures of rat hepatocytes treated with 100 µM PB are shown in Fig. 1A. WEM was apparently superior to other medium formulations in terms of the magnitude of CYP2B induction (on a per mg microsomal protein basis). MCM and HCM were similar in their capacity to sustain induction of CYP2B by PB, and DMEM was only slightly less effective when hepatocytes were maintained on Permanox dishes. The changes in PROD activity observed in cultures maintained in different media were also reflected qualitatively by marked increases in the immunoreactive protein on Western blots (Fig. 1B).
|
|
|
|
|
Concentration-Response Relation for P-450 Induction by PB.
The effects of PB concentration on the induction of PROD activity in
cultures of hepatocytes maintained in either WEM or MCM are shown in
Fig. 6A. A concentration-dependent
increase in microsomal PROD activity was observed between 10 and 250 µM PB in cultures of hepatocytes maintained in either medium. At
higher concentrations, PB caused a marked reduction in PROD activity.
In contrast to CYP2B activity, CYP1A (7-ethoxyresorufin
O-dealkylase) and CYP3A (testosterone
6
-hydroxylase) activities did not increase significantly over
control levels at concentrations of PB below 250 µM, but increased in
a concentration-dependent fashion at higher doses of PB (data not
shown).
|
Time Course of P-450 Induction Response. The effects of treatment time on CYP2B enzyme induction by PB (100 µM) are shown in Fig. 7. PB caused a time-dependent increase in the rate of PROD over the first 72 h of treatment. However, PROD activity did not appear to be increased further by an additional 24 h of treatment with the inducer. The increase in PROD activity observed over the first 72 h was paralleled by a corresponding increase in immunoreactive CYP2B protein (Fig. 7, top).
|
Induction of Other Major P-450 Subfamilies In Vitro.
The culture conditions found to be both optimal and the most
time-effective for assessing the induction of CYP2B enzymes, namely
MCM, collagen-coated Permanox dishes, and a Matrigel overlay, were
utilized to examine the induction of other P-450 enzymes. Figure
8 shows the results of three separate
experiments designed to examine the induction of CYP1A, CYP2B, CYP3A,
and CYP4A by
-naphthoflavone, PB, dexamethasone, and clofibric acid
in primary cultures of rat hepatocytes. Induction of rat CYP1A, CYP2B,
CYP3A, and CYP4A enzymes was determined in microsomes prepared from
three separate groups of hepatocytes, based on measurements of
7-ethoxyresorufin O-dealkylase, PROD, testosterone
6
-hydroxylation, and lauric acid 12-hydroxylation, respectively
(Pearce et al., 1996
). The corresponding means ± S.E. for each
group are compared with representative values obtained from liver
microsomes from male rats treated with P-450 enzyme inducers in Table
1. The results showed that the culture
conditions found to be optimal for CYP2B induction supported the
induction of CYP1A, CYP3A, and CYP4A as well. In addition, induction of
these P-450 enzymes in cultured rat hepatocytes was reproducible from
one experiment to the next and, generally, within a factor of 2 to 4 of
induced activities observed in vivo, with the exception of the
induction of CYP1A by
-naphthoflavone (Table 1).
|
|
| |
Discussion |
|---|
|
|
|---|
Media and Overlay Effects on P-450 Enzyme Induction.
The aim of this study was to examine in vitro conditions for evaluating
drugs and other xenobiotics as CYP inducers in primary cultures of rat
hepatocytes. Effects of media formulation and extracellular matrix
overlay were assessed on CYP induction by prototypical inducers in rat
hepatocyte cultures to determine the optimum response in vitro. CYP2B
induction was chosen as the target response because it is one of the
most liver-selective in its regulation and has historically been one of
the most difficult responses to restore in primary cultures of rat
hepatocytes (LeCluyse et al., 1996b
). Four medium formulations, namely,
DMEM, WEM, MCM, and HCM, were chosen to represent both standard
formulations, which are easily obtained commercially (WEM, DMEM) and
enriched formulations, which contain superphysiological concentrations of certain components, especially amino acids (MCM, HCM; LeCluyse et
al., 1996b
).
PB Concentration Response.
The importance of drug concentration is illustrated in Fig. 6, which
shows the enzyme-inducing effects of a wide range of concentrations of
PB in cultured rat hepatocytes. Over the range of 10 to 100 µM, PB
caused a concentration-dependent induction of PROD activity. A plateau
was observed between 100 and 300 µM (a range that compares favorably
with plasma concentrations in rats administered PB at sedating dosages
of 80-100 mg/kg, which is the dosage range typically used to achieve
maximal CYP2B induction in vivo; Madan et al., 1999
). At concentrations
greater than 300 µM, the ability of PB to induce CYP2B activity
steadily declined (as did the levels of immunoreactive protein), such
that millimolar concentrations of PB were no more effective than 10 µM PB at inducing CYP2B enzymes. The apparent loss of CYP2B induction
at high dosages of PB was not a consequence of cell toxicity, and,
indeed, millimolar concentrations of PB were extremely effective at
inducing CYP1A1, a phenomenon that is not observed in vivo (arguably
because millimolar concentrations of PB cannot be achieved in vivo),
but that has been reported as an in vitro phenomenon by other
investigators (Sidhu et al., 1993
). A practical consequence of the
bell-shaped curve shown in Fig. 6 is that new chemical entities should
be examined for their ability to induce CYP at multiple concentrations, preferably over a range that is clinically and/or toxicologically relevant.
In Vitro Prediction of P-450 Induction.
The results from these studies emphasize three important features of
the rat hepatocyte culture technique for measuring P-450 enzyme
induction. First, overall, the rat hepatocyte technique for measuring
P-450 enzyme induction in vitro is suitably reproducible. Second, the
in vitro technique provides a sensitive method for detecting P-450
enzyme induction because the control enzyme activities are lower than
those observed in vivo, whereas the induced enzyme activities for
CYP2B, CYP3A, and CYP4A are comparable (within a factor of 2-4) to
those observed in vivo (Table 1; Parkinson, 1996
). By contrast, the
induced values for CYP1A in vitro were only within a factor of ~7 to
those observed in vivo, yet the fold induction observed for CYP1A was
essentially the same in vivo and in vitro. It is clear from a
comparison of in vitro and ex vivo data that induction of P-450
activity in cultured rat hepatocytes does not simply involve restoring
activity to the original control level, an observation that was
confirmed by Western immunoblotting. Third, cultured rat hepatocytes
responded to all four types of P-450 inducers examined. In this
context, it is noteworthy that we place considerable emphasis on the
response elicited by PB. Induction of CYP2B enzymes by PB is the least robust of the P-450 induction responses depicted in Fig. 8. As a rule
of thumb, hepatocytes that respond well to PB will respond to the other
types of P-450 inducers. In contrast, it is possible for hepatocytes to
respond to CYP1A inducers (as do most extrahepatic tissues and several
immortalized cell lines) and yet not respond to PB (which fails to
induce in most extrahepatic tissues and immortalized cell lines,
suggesting that induction of CYP2B enzymes is highly dependent on the
expression of certain liver-specific genes).
| |
Acknowledgments |
|---|
We thank Rick Gould, Kenda Marcucci, Jason Latham, Kevin Smith, D. James Coon, and Scott Barros for technical assistance.
| |
Footnotes |
|---|
Received January 22, 1999; accepted April 27, 1999.
1 Present address: School of Pharmacy, Division of Drug Delivery and Disposition, CB# 7360, Beard Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
2 Present address: Cerep, Inc., 15318 NE 95th St., Redmond, WA 98052.
This work was funded in part by National Institutes of Health Grants ES-03765 and GM-37044, Du Pont Pharmaceuticals Company, Pfizer, Inc., and the Procter and Gamble International Program for Animal Alternatives.
Send reprint requests to: Dr. Ajay Madan, XenoTech, LLC, 3800 Cambridge, Kansas City, KS 66103.
| |
Abbreviations |
|---|
Abbreviations used are: CYP, cytochrome P-450 enzymes; DMEM, Dulbecco's modified Eagle's medium; HCM, hepatocyte culture medium; ITS+, insulin, transferrin, selenium, linoleic acid, and BSA supplement; MCM, modified Chee's medium; PROD, 7-pentoxyresorufin O-dealkylase; WEM, Williams' E medium; PB, phenobarbital.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Acharya, J. C. Engel, and M. A. Correia Hepatic CYP3A Suppression by High Concentrations of Proteasomal Inhibitors: A Consequence of Endoplasmic Reticulum (ER) Stress Induction, Activation of RNA-Dependent Protein Kinase-Like ER-Bound Eukaryotic Initiation Factor 2{alpha} (eIF2{alpha})-Kinase (PERK) and General Control Nonderepressible-2 eIF2{alpha} Kinase (GCN2), and Global Translational Shutoff Mol. Pharmacol., September 1, 2009; 76(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Page, M. C. Johnson, K. M. Olsavsky, S. C. Strom, H. Zarbl, and C. J. Omiecinski Gene Expression Profiling of Extracellular Matrix as an Effector of Human Hepatocyte Phenotype in Primary Cell Culture Toxicol. Sci., June 1, 2007; 97(2): 384 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Kienhuis, H. M. Wortelboer, J.-C. Hoflack, E. J. Moonen, J. C.S. Kleinjans, B. van Ommen, J. H. M. van Delft, and R. H. Stierum Comparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics Approach Drug Metab. Dispos., December 1, 2006; 34(12): 2083 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. H. Chang, J. Chen, and X. W. Teng DISTINCT ROLE OF BILOBALIDE AND GINKGOLIDE A IN THE MODULATION OF RAT CYP2B1 AND CYP3A23 GENE EXPRESSION BY GINKGO BILOBA EXTRACT IN CULTURED HEPATOCYTES Drug Metab. Dispos., February 1, 2006; 34(2): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Han, G. Lee, C. Hefner, J. J. Maher, and M. A. Correia Heme-Reversible Impairment of CYP2B1/2 Induction in Heme-Depleted Rat Hepatocytes in Primary Culture: Translational Control by a Hepatic {alpha}-Subunit of the Eukaryotic Initiation Factor Kinase? J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 128 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jemnitz, Z. Veres, G. Torok, E. Toth, and L. Vereczkey Comparative study in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction Mutagenesis, May 1, 2004; 19(3): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Tippin, G. Hamilton, L. Moore, E. J. Beaudet, S. Jolley, T. A. Brodie, R. C. Andrews, J. D. Becherer, D. L. McDougald, M. D. Gaul, et al. CYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-{alpha} CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANS Drug Metab. Dispos., July 1, 2003; 31(7): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Madan, R. A. Graham, K. M. Carroll, D. R. Mudra, L. A. Burton, L. A. Krueger, A. D. Downey, M. Czerwinski, J. Forster, M. D. Ribadeneira, et al. Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes Drug Metab. Dispos., April 1, 2003; 31(4): 421 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Graham, A. Downey, D. Mudra, L. Krueger, K. Carroll, C. Chengelis, A. Madan, and A. Parkinson In Vivo and in Vitro Induction of Cytochrome P450 Enzymes in Beagle Dogs Drug Metab. Dispos., November 1, 2002; 30(11): 1206 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rae, M. D. Johnson, M. E. Lippman, and D. A. Flockhart Rifampin Is a Selective, Pleiotropic Inducer of Drug Metabolism Genes in Human Hepatocytes: Studies with cDNA and Oligonucleotide Expression Arrays J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 849 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Burczynski, M. McMillian, J. B. Parker, S. Bryant, A. Leone, E. R. Grant, J. M. Thorne, Z. Zhong, R. A. Zivin, and M. D. Johnson Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay Drug Metab. Dispos., September 1, 2001; 29(9): 1243 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Hartley and C. D. Klaassen Detection of Chemical-Induced Differential Expression of Rat Hepatic Cytochrome P450 mRNA Transcripts Using Branched DNA Signal Amplification Technology Drug Metab. Dispos., May 1, 2000; 28(5): 608 - 616. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||